YU37113B - Process for obtaining substituted 3,4-dimethoxy-beta-phenyl-ethylamine - Google Patents

Process for obtaining substituted 3,4-dimethoxy-beta-phenyl-ethylamine

Info

Publication number
YU37113B
YU37113B YU3212/79A YU321279A YU37113B YU 37113 B YU37113 B YU 37113B YU 3212/79 A YU3212/79 A YU 3212/79A YU 321279 A YU321279 A YU 321279A YU 37113 B YU37113 B YU 37113B
Authority
YU
Yugoslavia
Prior art keywords
ethylamine
dimethoxy
beta
phenyl
obtaining substituted
Prior art date
Application number
YU3212/79A
Other versions
YU321279A (en
Inventor
R R Tuttle
J Mills
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22918877&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=YU37113(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of YU321279A publication Critical patent/YU321279A/en
Publication of YU37113B publication Critical patent/YU37113B/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C211/00—Compounds containing amino groups bound to a carbon skeleton
    • C07C211/01—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms
    • C07C211/26—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms of an unsaturated carbon skeleton containing at least one six-membered aromatic ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/45—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by condensation
    • C07C45/46—Friedel-Crafts reactions

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Cardiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
YU3212/79A 1972-04-12 1979-12-28 Process for obtaining substituted 3,4-dimethoxy-beta-phenyl-ethylamine YU37113B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US24346672A 1972-04-12 1972-04-12

Publications (2)

Publication Number Publication Date
YU321279A YU321279A (en) 1983-04-27
YU37113B true YU37113B (en) 1984-08-31

Family

ID=22918877

Family Applications (2)

Application Number Title Priority Date Filing Date
YU00976/73A YU36483B (en) 1972-04-12 1973-04-11 Process for obtaining substituted 3,4-dihydroxy-beta-phenetyl amines
YU3212/79A YU37113B (en) 1972-04-12 1979-12-28 Process for obtaining substituted 3,4-dimethoxy-beta-phenyl-ethylamine

Family Applications Before (1)

Application Number Title Priority Date Filing Date
YU00976/73A YU36483B (en) 1972-04-12 1973-04-11 Process for obtaining substituted 3,4-dihydroxy-beta-phenetyl amines

Country Status (31)

Country Link
JP (2) JPS5825656B2 (en)
KR (1) KR790000113B1 (en)
AR (1) AR203822A1 (en)
AT (1) AT323719B (en)
AU (1) AU472734B2 (en)
BE (1) BE798051A (en)
BG (1) BG23001A3 (en)
CA (1) CA1018188A (en)
CH (2) CH569691A5 (en)
CS (2) CS190448B2 (en)
CY (1) CY963A (en)
DD (1) DD107670B3 (en)
DE (1) DE2317710C2 (en)
DK (1) DK142750C (en)
ES (1) ES413639A1 (en)
FR (1) FR2182947B1 (en)
GB (1) GB1392674A (en)
HK (1) HK50178A (en)
HU (2) HU167597B (en)
IE (1) IE37511B1 (en)
IL (1) IL42016A (en)
KE (1) KE2870A (en)
MY (1) MY7800381A (en)
NL (1) NL174459C (en)
PH (1) PH11041A (en)
PL (2) PL90695B1 (en)
RO (2) RO65105A (en)
SE (1) SE399064B (en)
SU (1) SU496719A3 (en)
YU (2) YU36483B (en)
ZA (1) ZA732136B (en)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH585693A5 (en) * 1974-02-08 1977-03-15 Ciba Geigy Ag
US4342692A (en) * 1980-10-20 1982-08-03 Usv Pharmaceutical Corporation Pyrrolidines
ZA825227B (en) * 1981-07-22 1984-03-28 Syntex Inc Substituted pyrrolidine cardiovascular system regulators antihypertensives
JPS6061523A (en) * 1983-09-16 1985-04-09 Shionogi & Co Ltd Oral dobutamine pharmaceutical
IL85438A0 (en) * 1987-02-24 1988-07-31 Lilly Co Eli Improvements in or relating to dobutamine salts
JPH0383364U (en) * 1989-12-18 1991-08-23
AU658188B2 (en) * 1991-05-20 1995-04-06 Tsumura & Co. Phellodendrine analogs and allergy type IV suppressor containing the same as active ingredient
EP0620208B1 (en) * 1993-04-13 1997-07-09 Duphar International Research B.V Production of dobutamine compounds
DE69404063T2 (en) * 1993-04-13 1998-01-22 Duphar Int Res Manufacture of dobutamine compounds
PT1546088E (en) 2002-10-03 2015-03-16 Novaremed Ltd Compounds for use in the treatment of autoimmune diseases, immuno-allergical diseases and organ or tissue transplantation rejection
US7674829B2 (en) 2004-03-26 2010-03-09 Novaremed Limited Compounds for the treatment of AIDS and other viral diseases
GB0804213D0 (en) 2008-03-06 2008-04-16 New Era Biotech Ltd A method of printing or preventing pain
JP2013501006A (en) 2009-07-31 2013-01-10 コグニション セラピューティクス インク． Cognitive decline inhibitors
US8802734B2 (en) 2009-09-09 2014-08-12 Novaremed Limited Method of treating or preventing pain
BR112014004414A2 (en) * 2011-08-25 2017-03-28 Cognition Therapeutics Inc compositions and methods for treating neurodegenerative disease
BR112016017808B1 (en) 2014-01-31 2022-07-12 Cognition Therapeutics, Inc PHARMACEUTICALLY ACCEPTABLE COMPOUND OR SALT, USE OF A COMPOUND AND COMPOSITION FOR INHIBITING A BETAAMYLOID EFFECT IN A NEURONAL CELL
KR102614814B1 (en) 2017-05-15 2023-12-20 카그니션 테라퓨틱스, 인코퍼레이티드 Composition for treating neurodegenerative diseases
CN114524734B (en) * 2021-12-27 2024-04-26 嘉实（湖南）医药科技有限公司 Preparation method of dobutamine hydrochloride

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2276619A (en) * 1942-03-17 N-phentlaliphatic-dihtoroxyphentnl

Also Published As

Publication number Publication date
YU36483B (en) 1984-02-29
AR203822A1 (en) 1975-10-31
CA1018188A (en) 1977-09-27
IL42016A (en) 1976-05-31
YU97673A (en) 1982-02-25
IE37511B1 (en) 1977-08-03
BG23001A3 (en) 1977-05-20
DE2317710C2 (en) 1983-08-04
PL94207B1 (en) 1977-07-30
ZA732136B (en) 1974-03-27
CH580563A5 (en) 1976-10-15
HU166213B (en) 1975-02-28
AU5438573A (en) 1974-10-17
DK142750C (en) 1981-08-17
DD107670B3 (en) 1988-04-06
NL7305097A (en) 1973-10-16
DD107670A5 (en) 1974-08-12
JPS5825656B2 (en) 1983-05-28
FR2182947A1 (en) 1973-12-14
RO65105A (en) 1980-01-15
CH569691A5 (en) 1975-11-28
KR790000113B1 (en) 1979-03-20
JPS58131945A (en) 1983-08-06
CY963A (en) 1978-12-22
SU496719A3 (en) 1975-12-25
BE798051A (en) 1973-10-11
AU472734B2 (en) 1976-06-03
SE399064B (en) 1978-01-30
PH11041A (en) 1977-10-25
DE2317710A1 (en) 1973-10-18
HU167597B (en) 1975-11-28
GB1392674A (en) 1975-04-30
HK50178A (en) 1978-09-15
DK142750B (en) 1981-01-12
IL42016A0 (en) 1973-06-29
JPS497237A (en) 1974-01-22
NL174459C (en) 1984-06-18
CS190406B2 (en) 1979-05-31
KE2870A (en) 1978-09-01
YU321279A (en) 1983-04-27
FR2182947B1 (en) 1976-07-02
AT323719B (en) 1975-07-25
NL174459B (en) 1984-01-16
PL90695B1 (en) 1977-01-31
JPS6221343B2 (en) 1987-05-12
RO70892A (en) 1982-02-26
CS190448B2 (en) 1979-05-31
MY7800381A (en) 1978-12-31
ES413639A1 (en) 1976-01-16

Similar Documents

Publication Publication Date Title
YU254979A (en) Process for preparing new 3,4-dihydrocarbostyryl-derivatives
YU37113B (en) Process for obtaining substituted 3,4-dimethoxy-beta-phenyl-ethylamine
YU39715B (en) Process for obtaining substituted omega-pentanoprostaglandins
YU34884B (en) Process for preparing 1,2,3-tiadiazole derivatives
YU39297B (en) Process for preparing 6-phenyl-substituted 3-methyl-4-amino-5h-1,2,4-triazine-5-ones
YU133872A (en) Process for obtaining diphenyl-alkanoylamino-pyridines
YU36527B (en) Process for obtaining 3-hydroxy-cephalosporin
YU35775B (en) Process for obtaining d-homosteroids
YU40095B (en) Process for obtaining 1,2-dialkyl-3,5-diphenylpirazolium salts
YU36149B (en) Process for obtaining isopropylamines
YU269273A (en) Process for obtaining 2,10-dichloro-12-methyl-12h-dibenzo (d.g.)-(1,3)dioxocines
YU210473A (en) Process for obtaining novel oxo-3-dihydro-2,3-benzoxazine-1,4 derivatives
YU35149B (en) Process for obtaining 15 delta, 16-methylene-4-pregnene
YU229979A (en) Process for obtaining novel 1,4-benzodixane derivatives
YU146973A (en) Process for obtaining oxo-prostaglandins
YU318473A (en) Process for obtaining m-dioxane-5-methylamines
YU49973A (en) Process for obtaining n1-piperonyl-n4-3,7,11-trimethyl-2,6,10-dodecatrienyl-piperazine
YU36701B (en) Process for obtaining as-triazinoz5,6-ccquinoline derivatives
YU35273B (en) Process for obtaining bicyclomycine
YU265473A (en) Process for obtaining 7-acylamido-7-alkoxy-cephalosporins
YU240180A (en) Process for obtaining deacetoxy-cephalosporin
CS191448B1 (en) Process for preparing 6,7-dihydrobenztrazole
YU45373A (en) Process for preparing 6,9-dioxo-8-hydroxy-2-(3,4-dihydroxyphenyl)-bicyclo-(3,3,1)-7-nomene-3-01
YU146672A (en) Process for preparing substituted 2-arylaminoimidazolines-(2)
YU39001B (en) Process for preparing new 3,4-dihydrocarbostyryl derivatives